Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07643623
Recruiting
Neoadjuvant and Adjuvant Therapy Studies of Sintilimab Combined With Chemotherapy With or Without Ipilimumab N01 in Resectable Gastric/Gastroesophageal Junction Adenocarcinoma
Phase 2/3 · China · 1 site
Registry update: 14 Aug 2026
NCT07726888
Recruiting
Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis
Not applicable · China · 1 site
Registry update: 20 Oct 2026
NCT07437833
Recruiting
Psychophysiological Responses to Six Single-Session Self-Regulation Interventions in a Female Adult With ADHD and Stabilized Bipolar Disorder
Not applicable · Poland · 1 site
Registry update: 2 Nov 2026
2023-505575-69-01
Recruiting
Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
Phase 3 · Denmark, Spain, Finland, France, Italy, Netherlands, Poland, Sweden · 73 sites
Registry update: 13 Jul 2026
NCT07738614
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Phase 1 · Singapore, United States · 2 sites
Registry update: 20 Aug 2026
NCT07795164
Recruiting
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
Phase 3 · United States · 9 sites
Registry update: 23 Sept 2026
NCT07711184
Recruiting
A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer
Phase 1 · Australia, China · 7 sites
Registry update: 24 Sept 2026
NCT06419205
Recruiting
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
Phase 2 · Brazil, United States · 4 sites
Registry update: 1 Oct 2026
NCT07732400
Recruiting
A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)
Phase 1/2 · New Zealand, United States · 3 sites
Registry update: 1 Sept 2026
NCT07739485
Recruiting
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study
Phase 1/2 · China · 1 site
Registry update: 4 Aug 2026
NCT07695454
Recruiting
Imaging in Semaglutide Study
Not applicable · United States · 1 site
Registry update: 6 Oct 2026
NCT07754110
Recruiting
Effect of HABIT-ILE on Balance and Coordination Among Stroke Patients
Not applicable · Pakistan · 1 site
Registry update: 10 Aug 2026
NCT07533708
Recruiting
A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours
Phase 1 · China · 5 sites
Registry update: 11 Aug 2026
NCT07762092
Recruiting
A Post Authorization Registry Study of Participants Treated With LEQEMBI
Not applicable · Canada · 17 sites
Registry update: 5 Nov 2026
NCT07730879
Recruiting
How Wall Squat Exercise Affects Blood Pressure in People With High Blood Pressure and Treated Sleep Apnea (WALLPRESS)
Not applicable · Portugal · 1 site
Registry update: 29 Jul 2026
NCT07823842
Recruiting
T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPD
Not applicable · China · 1 site
Registry update: 16 Sept 2026
NCT07693699
Recruiting
Optimizing Sustainable Cuff Access and Training Pathways for Self-Measured Blood Pressure Monitoring in Primary Care
Not applicable · United States · 6 sites
Registry update: 12 Aug 2026
NCT07728019
Recruiting
Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM
Phase 2 · China · 1 site
Registry update: 22 Sept 2026
2026-525267-40-00
Recruiting
Intensified Monitoring of PhArmacology of Cabozantinib as a tool for Toxicity management in patients with renal cell carcinoma
Phase 4 · Italy · 2 sites
Registry update: 21 May 2026
NCT07798778
Recruiting
Clinical Evaluation of SRT-017 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
Early phase 1 · China · 1 site
Registry update: 1 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.